School of Electronics and Information, Northwestern Polytechnical University, Xi'an, China.
School of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, China.
Eur Arch Otorhinolaryngol. 2022 Aug;279(8):4127-4136. doi: 10.1007/s00405-022-07284-z. Epub 2022 Feb 5.
Human microbiome has been considered as the second genome of our body. The intratissue/intratumor microbiome analysis is a relatively new field and deserves more attention. In this study, we conducted a comprehensive analysis of microbiome signatures of head and neck squamous cell carcinoma (HNSC).
The intratumor microbiome profiling and clinicopathological information about a total of 177 HNSC samples, including 155 tumors and 22 adjacent normal tissues, were obtained from The Cancer Microbiome Atlas (TCMA) and The Cancer Genome Atlas (TCGA) databases. We identified the microbes that differed between tumors and normal tissues, and assessed their utility values as diagnostic biomarkers. The microbiome signatures under different conditions of clinicopathological parameters were also analyzed.
The intratissue microbiome profiles differed between tumor and normal samples of HNSC. The composition of four, six, and six microbes changed in tumors compared to normal tissues at the phylum, order, and genus levels, respectively (P < 0.05). Eight of the differential microbes performed well in distinguishing tumors from normal tissues (AUC > 0.7, P ≤ 0.001). The microbiome signature was found to be associated with tumor clinicopathological characteristics such as host-gender, host-age, tumor stage, and neoplasm histologic grade.
Overall, our results revealed an intratissue microbiome signature of HNSC. We concluded that the intratumor microbiome signature may also reflect human biology in both healthy and disease status, and provide novel perspective for microbiota research about their roles in tumors.
人类微生物组被认为是我们身体的第二基因组。组织内/肿瘤内微生物组分析是一个相对较新的领域,值得更多关注。在这项研究中,我们对头颈部鳞状细胞癌(HNSC)的微生物组特征进行了全面分析。
从癌症微生物组图谱(TCMA)和癌症基因组图谱(TCGA)数据库中获得了总共 177 个 HNSC 样本的肿瘤内微生物组分析和临床病理信息,包括 155 个肿瘤和 22 个相邻正常组织。我们鉴定了肿瘤和正常组织之间存在差异的微生物,并评估了它们作为诊断生物标志物的实用价值。还分析了不同临床病理参数条件下的微生物组特征。
HNSC 的肿瘤和正常组织内的组织内微生物组谱存在差异。与正常组织相比,肿瘤组织中四个、六个和六个微生物的组成分别在门、目和属水平上发生了变化(P < 0.05)。八种差异微生物在区分肿瘤和正常组织方面表现良好(AUC > 0.7,P ≤ 0.001)。微生物组特征与肿瘤临床病理特征相关,如宿主性别、宿主年龄、肿瘤分期和肿瘤组织学分级。
总体而言,我们的结果揭示了 HNSC 的组织内微生物组特征。我们得出结论,肿瘤内微生物组特征也可能反映健康和疾病状态下的人类生物学,并为微生物组在肿瘤中的作用提供了新的研究视角。